Skip to main content
. Author manuscript; available in PMC: 2021 Jul 10.
Published in final edited form as: ACS Infect Dis. 2020 Jun 24;6(7):1976–1997. doi: 10.1021/acsinfecdis.0c00326

Figure 9.

Figure 9.

Mass spectral data for ctDNA treated with tilimycin. A.) MS1 EIC of 484.1939 m/z. B.) MS2 data dependent event for 484.1939 m/z. C.) MS3 triggered event for 484.1939→368.1466 m/z (neutral loss of deoxyribose). D.) MS2 mass spectrum from fragmentation of 484 m/z at retention time = 15.19 min. E.) MS3 mass spectrum from fragmentation of 484.1939→368.1466 m/z at retention time = 15.20 min.